Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern Cooperative Oncology Group E2303

Amanda Psyrri, Ju Whei Lee, Eirini Pectasides, Maria Vassilakopoulou, Efstratios K. Kosmidis, Barbara A. Burtness, David L. Rimm, Harold J. Wanebo, Arlene A. Forastiere

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern Cooperative Oncology Group E2303'. Together they form a unique fingerprint.

Medicine & Life Sciences